Open Menu Close Menu

Funding for basic science, clinical, population/epidemiologic and translational research on cardiomyopathies affecting children aged 18 years and younger. This includes support for studies focused on the causes, evaluation or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular and left ventricular non-compaction cardiomyopathy as it relates to the pediatric population.